GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Aosaikang Pharmaceutical Co Ltd (SZSE:002755) » Definitions » Cyclically Adjusted Revenue per Share

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Cyclically Adjusted Revenue per Share : ¥4.67 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Aosaikang Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Beijing Aosaikang Pharmaceutical Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥0.427. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥4.67 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Beijing Aosaikang Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was -5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-02), Beijing Aosaikang Pharmaceutical Co's current stock price is ¥10.54. Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥4.67. Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 2.26.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Beijing Aosaikang Pharmaceutical Co was 2.41. The lowest was 1.56. And the median was 2.08.


Beijing Aosaikang Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Aosaikang Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Beijing Aosaikang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.69

Beijing Aosaikang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.95 4.84 4.80 4.69 4.67

Competitive Comparison of Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Beijing Aosaikang Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beijing Aosaikang Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.427/115.2271*115.2271
=0.427

Current CPI (Mar. 2024) = 115.2271.

Beijing Aosaikang Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.902 98.200 1.058
201409 9.108 98.900 10.612
201412 1.348 99.000 1.569
201503 0.824 99.900 0.950
201506 0.408 99.500 0.472
201509 1.613 100.500 1.849
201512 0.454 100.600 0.520
201603 0.182 102.200 0.205
201606 0.193 101.400 0.219
201609 0.253 102.400 0.285
201612 0.319 102.600 0.358
201703 0.191 103.200 0.213
201706 0.728 103.100 0.814
201709 0.576 104.100 0.638
201712 4.163 104.500 4.590
201803 1.287 105.300 1.408
201806 1.316 104.900 1.446
201809 1.332 106.600 1.440
201812 1.306 106.500 1.413
201903 1.184 107.700 1.267
201906 1.285 107.700 1.375
201909 1.330 109.800 1.396
201912 1.052 111.200 1.090
202003 0.732 112.300 0.751
202006 0.926 110.400 0.966
202009 1.298 111.700 1.339
202012 1.142 111.500 1.180
202103 0.993 112.662 1.016
202106 0.789 111.769 0.813
202109 0.837 112.215 0.859
202112 0.731 113.108 0.745
202203 0.553 114.335 0.557
202206 0.310 114.558 0.312
202209 0.508 115.339 0.508
202212 0.437 115.116 0.437
202303 0.346 115.116 0.346
202306 0.422 114.558 0.424
202309 0.450 115.339 0.450
202312 0.343 114.781 0.344
202403 0.427 115.227 0.427

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Beijing Aosaikang Pharmaceutical Co  (SZSE:002755) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=10.54/4.67
=2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Beijing Aosaikang Pharmaceutical Co was 2.41. The lowest was 1.56. And the median was 2.08.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Beijing Aosaikang Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Beijing Aosaikang Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Business Description

Traded in Other Exchanges
N/A
Address
South Fourth Ring Road, Building 28 , 7th District, No. 188, Fengtai District, Beijing, CHN, 100070
Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.
Executives
Wang Zheng Yong Executives
Li Xiao Xin Supervisors
Ren Wei Rong Directors, executives
Chen Qing Cai Directors, Directors, and Executives
Du Chao Yang Executives
Ma Yao Chuan Director
Wu Zhan Feng Supervisors
Guo Hong Jie Director

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Headlines

No Headlines